The estimated Net Worth of Thomas E Griffin is at least $2.68 ezer dollars as of 13 April 2018. Thomas Griffin owns over 3,346 units of Helius Medical Technologies Inc stock worth over $2,677 and over the last 8 years Thomas sold HSDT stock worth over $0.
Thomas has made over 1 trades of the Helius Medical Technologies Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently Thomas bought 3,346 units of HSDT stock worth $24,995 on 13 April 2018.
The largest trade Thomas's ever made was buying 3,346 units of Helius Medical Technologies Inc stock on 13 April 2018 worth over $24,995. On average, Thomas trades about 669 units every 0 days since 2017. As of 13 April 2018 Thomas still owns at least 3,346 units of Helius Medical Technologies Inc stock.
You can see the complete history of Thomas Griffin stock trades at the bottom of the page.
Thomas's mailing address filed with the SEC is C/O HELIUS MEDICAL TECHNOLOGIES, INC., 642 NEWTOWN YARDLEY ROAD, SUITE 100, NEWTOWN, PA, 18940.
Over the last 9 years, insiders at Helius Medical Technologies Inc have traded over $0 worth of Helius Medical Technologies Inc stock and bought 1,827,117 units worth $3,547,767 . The most active insiders traders include Dane Andreeff, Blane Walter és Philippe Deschamps. On average, Helius Medical Technologies Inc executives and independent directors trade stock every 121 days with the average trade being worth of $58,628. The most recent stock trade was executed by Dane Andreeff on 14 December 2023, trading 5,000 units of HSDT stock currently worth $40,500.
helius medical technologies, inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. the company's product is portable neuromodulation stimulator (pons), a medical device in canada for the treatment of chronic balance deficit due to mild-to-moderate traumatic brain injury. its pons device treats neurostimulation of cranial nerves via the tongue to restore lost function. the company is headquartered in newtown, pennsylvania.
Helius Medical Technologies Inc executives and other stock owners filed with the SEC include: